Find an Article

Filter articles

Applied Filters

Showing 191 to 200 of 338 results

Biomedical patents: the quest for balance

US18-08-2016Pat Carson and Mira Atanassova Mulvaney

The US Supreme Court’s Mayo and Myriad decisions have brought challenges to subject matter eligibility to the forefront in the biomedical industry, but they do not signal the end of biomedical patents. Pat Carson and Mira Atanassova Mulvaney of Kirkland & Ellis report.

China v US: what can be patented in the life sciences field?

China, US09-08-2016Yu Guo

The US and China take very different approaches to the patentability of a range of inventions in the life sciences field, as Yu Guo of China Patent Agent reports.

IPR: five tips for successfully challenging Orange Book patents

US04-08-2016Mark Remus

Inter-partes reviews (IPRs) can be a powerful weapon against patents listed in the Orange Book. However, IPR practice favours a petitioner who has carefully thought about the issues and crafted the best strategy, says Mark Remus of Brinks Gilson & Lione.

Drug price regulation in Brazil: Roche faces IP rights abuse claims

Brazil02-08-2016Anderson Ribeiro and Ricardo Campello

The Brazilian Federal Prosecutor’s Office has taken court action against Roche for allegedly abusing IP rights in its sales of Herceptin to state governments. Anderson Ribeiro and Ricardo Campello of Provedel Advogados analyse the case.

Ariosa v Sequenom: keeping the Mayo test in place

US21-07-2016Stephen Stout and Rachael McClure

Despite the clamour for more guidance on the scope and application of the Mayo test on patent eligibility, the US Supreme Court denied Sequenom’s petition in its dispute with Ariosa, as Stephen Stout and Rachael McClure of Vinson & Elkins explain.

Running an efficient clinical drug trial

International19-07-2016Charlie Nicholson

Everyone benefits from an efficiently run clinical drug study, including sponsors, contract research organisations, the investigator sites where patients are treated and observed, and most of all, patients, says Charlie Nicholson of Premier Research.

An overview: revised biotech patent guidelines in Canada

Canada22-06-2016Jason Markwell and Stephanie Anderson

The Canadian Intellectual Property Office has updated its guidelines on procedural and examination practices, with some changes affecting biotechnology and medicinal inventions, explain Jason Markwell and Stephanie Anderson of Belmore Neidrauer.

A proud history of innovation

Mexico10-06-2016Nuria Becerril

IP and innovation in Mexico has come a long way, and the country’s part in international trade treaties will provide further great opportunities, says Nuria Becerril of Becerril, Coca & Becerril.

Brighter future for natural resources

Brazil09-06-2016Andrea Granthon and Tatiana Schuenck

The system governing access to genetic resources in Brazil has been strengthened by a recent legal update, explain Andrea Granthon and Tatiana Schuenck of Luiz Leonardos & Advogados.

Brazil’s quest to beat dengue fever

Brazil08-06-2016Gabriel Di Blasi and Jorge Kalil

Aided by strong patent protection, efforts are continuing in Brazil to develop a vaccine against the notorious dengue fever. Gabriel Di Blasi of Di Blasi, Parente & Associados and Jorge Kalil of the Instituto Butantan explain more.

Showing 191 to 200 of 338 results